Cilomilast
Cilomilast
Cilomilast (pronounced as /si-lo-mi-last/) is a selective PDE4 inhibitor developed for treating respiratory disorders such as COPD and Asthma.
Etymology
The term 'Cilomilast' is derived from the systematic IUPAC name 'Cilomilast', which is an amalgamation of parts of the chemical name 'Cyclohexyl-N-(3,5-dichloropyridin-4-yl)-4-difluoromethoxy-N-methylbenzamide'.
Usage
Cilomilast is used primarily in the treatment of COPD. It works by reducing inflammation in the lungs, thereby improving airflow and reducing symptoms such as shortness of breath.
Related Terms
- PDE4 inhibitor: A type of drug that blocks the action of phosphodiesterase 4, an enzyme involved in inflammatory responses.
- COPD: A type of obstructive lung disease characterized by long-term breathing problems and poor airflow.
- Asthma: A long-term inflammatory disease of the airways of the lungs.
See Also
- Roflumilast: Another PDE4 inhibitor used in the treatment of COPD.
- Bronchodilator: A substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs.
External links
- Medical encyclopedia article on Cilomilast
- Wikipedia's article - Cilomilast
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski